SCHEMBL20805367

SCHEMBL20805367

CC1OC(CO)[C@H](O)C1O

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS1 P09382 2/20 0.48
LGALS3 P17931 2/20 0.48
LGALS9 O00182 1/20 0.48
LGALS8 O00214 1/20 0.48
PYGB P11216 3/20 0.41
GAA P10253 1/20 0.41
OGA O60502 2/20 0.40
HEXA P06865 1/20 0.40
HEXB P07686 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.39
FUCA1 P04066 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13219682 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL264470 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL13396024 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL12114703 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL23844307 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL22174657 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL25090768 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL21621598 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL21146567 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB
SCHEMBL7599989 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8PYGB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190077797-A1 PROCESSES FOR PREPARING 2-DIHALO RIBOLACTONES EMORY UNIVERSITY 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077797-A1 PROCESSES FOR PREPARING 2-DIHALO RIBOLACTONES DERA, DPYD, DUS2 LGALS1 902/4885LGALS3 1570/4885LGALS9 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.